Delivery Order SPE2DB25D3201-SPE2DB25FNVRT
- Not listed
- The Defense Logistics Agency awarded a $94,770.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Varivax vaccine with diluents. The contract, which is classified as a child delivery order under a larger indefinite delivery vehicle, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 19, 2025. This award was made through open competition with no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $5,265.05 on September 3, 2025, for the supply of Varivax vaccine with diluents. This is a firm fixed-price delivery order with no set-aside designation, scheduled for completion by September 24, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single transaction under the company's larger federal contract portfolio supporting military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $1,032.11 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. This is a firm fixed price, competitively awarded delivery order with an ultimate completion date of September 29, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,053.01 to AmerisourceBergen Drug Corp for Varivax vaccine with diluents, with a completion deadline of August 21, 2025. This is a firm fixed price, non-set-aside contract, with performance based in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger pharmaceutical supply relationship with the federal government, demonstrating the company's role as a critical vaccine...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Varivax vaccine with diluents, with a ceiling value of $2,085.12 and an ultimate completion date of September 30, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,064.22 to AmerisourceBergen Drug Corp for Varivax vaccine with diluents on August 25, 2025, with an ultimate completion date of September 16, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal healthcare vendor...
- The Defense Logistics Agency (DLA) awarded a $3,793.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents. The contract, issued on July 14, 2025, is scheduled for ultimate completion by August 4, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order was competitively awarded without any set-aside designation, demonstrating the contractor's capability to compete in open federal...
- The Defense Logistics Agency awarded a delivery order valued at $3,159.03 to AmerisourceBergen Drug Corp for Varivax vaccine with diluents, with an ultimate completion date of August 22, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, competitively awarded through open procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents valued at $22,761.00 under a firm fixed price contract type. The order was competitively awarded without set-aside designation and is scheduled for completion by September 26, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents one of multiple pharmaceutical procurement...
- The Defense Logistics Agency awarded a $3,096.33 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents, with an ultimate completion date of August 12, 2025. This competitively awarded, non-set-aside contract reflects AmerisourceBergen's critical role as a pharmaceutical distributor supporting federal medical procurement needs. The delivery order is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery...
- SPE2DB25D3201Indefinite Delivery Contract
- SPE2DB25D3201-SPE2DB25FNVRTDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,158.88 on August 14, 2025, for Varivax vaccine with diluents to be delivered to Conshohocken, Pennsylvania, with a completion date of September 5, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a small-value transaction within AmerisourceBergen's broader federal pharmaceutical supply portfolio. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime contract vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies globally to support military healthcare programs, including vaccines, specialty medications, and medical commodities for customers such as the Defense Health Agency and U.S. Coast Guard. The company's consistent receipt of competitive delivery orders reflects its established capability to meet federal medical procurement requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 8/14/25 |